Palvella Therapeutics Statistics Share Statistics Palvella Therapeutics has 11.06M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 11.06M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 46.52% Shares Floating n/a Failed to Deliver (FTD) Shares 10,101 FTD / Avg. Volume 6.93%
Short Selling Information The latest short interest is 643.13K, so 5.82% of the outstanding
shares have been sold short.
Short Interest 643.13K Short % of Shares Out 5.82% Short % of Float 7.08% Short Ratio (days to cover) 5.3
Valuation Ratios The PE ratio is -1.53 and the forward
PE ratio is -16.17.
Palvella Therapeutics's PEG ratio is
0.01.
PE Ratio -1.53 Forward PE -16.17 PS Ratio 0 Forward PS n/a PB Ratio 0.43 P/FCF Ratio -2.46 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Palvella Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.33,
with a Debt / Equity ratio of 0.19.
Current Ratio 7.33 Quick Ratio 7.33 Debt / Equity 0.19 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -3.26
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.25M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.03, so Palvella Therapeutics's
price volatility has been lower than the market average.
Beta -0.03 52-Week Price Change n/a 50-Day Moving Average 37.97 200-Day Moving Average n/a Relative Strength Index (RSI) 65.97 Average Volume (20 Days) 145,856
Income Statement
Revenue n/a Gross Profit n/a Operating Income -14.1M Net Income -17.43M EBITDA -13.12M EBIT -13.12M Earnings Per Share (EPS) -7.83
Full Income Statement Balance Sheet The company has 83.6M in cash and 0 in
debt, giving a net cash position of 83.6M.
Cash & Cash Equivalents 83.6M Total Debt n/a Net Cash n/a Retained Earnings -93.73M Total Assets 73.75M Working Capital 64.13M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.84M
and capital expenditures 0, giving a free cash flow of -10.84M.
Operating Cash Flow -10.84M Capital Expenditures n/a Free Cash Flow -10.84M FCF Per Share -4.87
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PVLA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PVLA is $55,
which is 1.6% higher than the current price. The consensus rating is "Buy".
Price Target $55 Price Target Difference 1.6% Analyst Consensus Buy Analyst Count 10
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 23, 2024. It was a
backward
split with a ratio of 1:80.
Last Split Date Apr 23, 2024 Split Type backward Split Ratio 1:80
Scores Altman Z-Score 10.99 Piotroski F-Score 1
